デフォルト表紙
市場調査レポート
商品コード
1390708

バイオサージェリー市場:世界の産業動向、シェア、規模、成長、機会、2023-2028年予測

Biosurgery Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日: | 発行: IMARC | ページ情報: 英文 147 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
バイオサージェリー市場:世界の産業動向、シェア、規模、成長、機会、2023-2028年予測
出版日: 2023年11月24日
発行: IMARC
ページ情報: 英文 147 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

バイオサージェリーの世界市場規模は2022年に130億米ドルに達しました。今後、IMARC Groupは、2028年までに195億米ドルに達し、2022年から2028年の間に6.99%の成長率(CAGR)を示すと予測しています。

バイオサージェリーとは、天然素材、合成素材、半合成素材を用いて外科的切開や傷を塞ぐ医療処置です。過剰な出血を防ぎ、創傷や組織を密封するための接着を提供し、損傷した組織や骨を修復するために広く使用されています。バイオサージェリーは通常、さまざまな止血剤、シーラント、軟部組織修復剤、骨移植代用剤、癒着防止剤、ステープルライン補強剤などを通して行われます。また、天然の同種移植片、培養上皮自家移植片、異種移植片を利用し、術中・術後の合併症を最小限に抑え、患者の回復を早める。その結果、神経外科、心臓血管外科、整形外科、脊椎外科、胸部外科、再建外科などの手術に広く使用されています。

バイオサージェリー市場の動向:

外科的処置による治療を必要とする筋骨格系疾患の有病率の増加は、市場の成長を促進する主な要因の1つです。さらに、骨粗しょう症やその他の慢性疾患を患いやすい老年人口の増加が、市場の成長を後押ししています。患者やヘルスケアプロバイダーは、従来使用されてきた縫合糸やステープルの代わりに、低侵襲性(MI)止血剤や外科用シーラントを使用することで、患者の効果的な出血管理のためにバイオサージェリーを広く採用しています。これに伴い、スポーツ関連傷害や偶発的外傷の増加も市場の成長に寄与しています。さらに、バイオサージェリー用のプラズマベースの多機能・多用途製品の開発など、さまざまな技術の進歩も市場の成長を後押ししています。その他の要因としては、特に新興経済諸国におけるヘルスケアインフラの大幅な改善や、広範な研究開発(R&D)活動などが挙げられ、市場の成長を後押しすると予想されます。

本レポートで扱う主な質問

  • 世界のバイオサージェリー市場はこれまでどのように推移してきたのか?
  • COVID-19が世界のバイオサージェリー市場に与えた影響は?
  • 主要な地域市場は?
  • 製品別の市場内訳は?
  • 由来別の市場内訳は?
  • 用途別の市場内訳は?
  • エンドユーザー別の市場内訳は?
  • 業界のバリューチェーンにおける様々な段階とは?
  • 業界の主な促進要因と課題は何か?
  • 世界のバイオサージェリー市場の構造と主要プレーヤーは?
  • 業界の競合の程度は?

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界のバイオサージェリー市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳:製品別

  • 骨移植代替物
    • 市場動向
    • 市場予測
  • 軟組織アタッチメント
    • 市場動向
    • 市場予測
  • 止血剤
    • 市場動向
    • 市場予測
  • 外科用シーラントと接着剤
    • 市場動向
    • 市場予測
  • 接着バリア
    • 市場動向
    • 市場予測
  • ステープルライン補強
    • 市場動向
    • 市場予測

第7章 市場内訳:由来別

  • 天然/生物製剤
    • 市場動向
    • 市場予測
  • 合成品
    • 市場動向
    • 市場予測

第8章 市場内訳:用途別

  • 整形外科
    • 市場動向
    • 市場予測
  • 一般外科
    • 市場動向
    • 市場予測
  • 神経外科
    • 市場動向
    • 市場予測
  • 心臓血管外科
    • 市場動向
    • 市場予測
  • 婦人科外科
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳:エンドユーザー別

  • 病院
    • 市場動向
    • 市場予測
  • 診療所
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳:地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳:国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Becton Dickinson and Company
    • CryoLife Inc.
    • CSL Limited
    • Hemostasis LLC
    • Integra Lifesciences Holdings Corporation
    • Johnson & Johnson
    • Medtronic plc
    • Pfizer Inc.
    • Sanofi S.A.
    • Smith & Nephew plc
    • Stryker Corporation
    • Surgalign Spine Technologies Inc.
図表

List of Figures

  • Figure 1: Global: Biosurgery Market: Major Drivers and Challenges
  • Figure 2: Global: Biosurgery Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Biosurgery Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Biosurgery Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Biosurgery Market: Breakup by Source (in %), 2022
  • Figure 6: Global: Biosurgery Market: Breakup by Application (in %), 2022
  • Figure 7: Global: Biosurgery Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Biosurgery Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Biosurgery (Bone-Graft Substitutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Biosurgery (Bone-Graft Substitutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Biosurgery (Soft-Tissue Attachments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Biosurgery (Soft-Tissue Attachments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Biosurgery (Hemostatic Agents) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Biosurgery (Hemostatic Agents) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Biosurgery (Surgical Sealants and Adhesives) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Biosurgery (Surgical Sealants and Adhesives) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Biosurgery (Adhesion Barriers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Biosurgery (Adhesion Barriers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Biosurgery (Staple Line Reinforcement) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Biosurgery (Staple Line Reinforcement) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Biosurgery (Natural/Biologics Products) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Biosurgery (Natural/Biologics Products) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Biosurgery (Synthetic Products) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Biosurgery (Synthetic Products) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Biosurgery (Orthopedic Surgery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Biosurgery (Orthopedic Surgery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Biosurgery (General Surgery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Biosurgery (General Surgery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Biosurgery (Neurological Surgery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Biosurgery (Neurological Surgery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Biosurgery (Cardiovascular Surgery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Biosurgery (Cardiovascular Surgery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Biosurgery (Gynecological Surgery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Biosurgery (Gynecological Surgery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Biosurgery (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Biosurgery (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Biosurgery (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Biosurgery (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Global: Biosurgery (Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Global: Biosurgery (Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Global: Biosurgery (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Global: Biosurgery (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: North America: Biosurgery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: North America: Biosurgery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: United States: Biosurgery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: United States: Biosurgery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Canada: Biosurgery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Canada: Biosurgery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Asia-Pacific: Biosurgery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Asia-Pacific: Biosurgery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: China: Biosurgery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: China: Biosurgery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Japan: Biosurgery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Japan: Biosurgery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: India: Biosurgery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: India: Biosurgery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: South Korea: Biosurgery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: South Korea: Biosurgery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Australia: Biosurgery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Australia: Biosurgery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Indonesia: Biosurgery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Indonesia: Biosurgery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Others: Biosurgery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Others: Biosurgery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Europe: Biosurgery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Europe: Biosurgery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Germany: Biosurgery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Germany: Biosurgery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: France: Biosurgery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: France: Biosurgery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: United Kingdom: Biosurgery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: United Kingdom: Biosurgery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Italy: Biosurgery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Italy: Biosurgery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Spain: Biosurgery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Spain: Biosurgery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Russia: Biosurgery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Russia: Biosurgery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Others: Biosurgery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Others: Biosurgery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Latin America: Biosurgery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Latin America: Biosurgery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Brazil: Biosurgery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Brazil: Biosurgery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Mexico: Biosurgery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Mexico: Biosurgery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: Others: Biosurgery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 88: Others: Biosurgery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: Middle East and Africa: Biosurgery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 90: Middle East and Africa: Biosurgery Market: Breakup by Country (in %), 2022
  • Figure 91: Middle East and Africa: Biosurgery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 92: Global: Biosurgery Industry: SWOT Analysis
  • Figure 93: Global: Biosurgery Industry: Value Chain Analysis
  • Figure 94: Global: Biosurgery Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Biosurgery Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Biosurgery Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Biosurgery Market Forecast: Breakup by Source (in Million US$), 2023-2028
  • Table 4: Global: Biosurgery Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: Biosurgery Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Biosurgery Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Biosurgery Market: Competitive Structure
  • Table 8: Global: Biosurgery Market: Key Players
目次
Product Code: SR112023A4522

Abstract

The global biosurgery market size reached US$ 13.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 19.5 Billion by 2028, exhibiting a growth rate (CAGR) of 6.99% during 2022-2028.

Biosurgery is a medical procedure that involves the use of natural, synthetic or semi-synthetic materials to seal surgical incisions and wounds. It is widely used for preventing excessive blood loss, providing adhesion for wound or tissue sealing and repairing damaged tissues and bones. Biosurgeries are usually conducted through various hemostatic, sealant, soft tissue repair, bone graft substitute, adhesion prevention and staple line reinforcement products. They also utilize natural allografts, cultured epithelial autografts and xenografts for minimizing intra and post-operative complications and promoting faster recovery of the patients. As a result, they are widely used for neurological, cardiovascular, orthopedic, spinal, thoracic and reconstruction surgeries.

Biosurgery Market Trends:

The increasing prevalence of musculoskeletal disorders that require treatment through surgical procedures is one of the key factors driving the growth of the market. Moreover, the rising geriatric population, which is more prone to osteoporosis and other chronic medical ailments, is providing a thrust to the market growth. Patients and healthcare providers are widely adopting biosurgeries for effective blood loss management in patients through minimally invasive (MI) hemostatic agents and surgical sealants in place of traditionally used sutures and staples. In line with this, the rising incidents of sports-related injuries and accidental traumas is also contributing to the growth of the market. Additionally, various technological advancements, such as the development of plasma-based, multi-functional and multi-use products for biosurgeries, are favoring the growth of the market. Other factors, including significant improvements in the healthcare infrastructure, especially in the developing economies, along with extensive research and development (R&D) activities, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global biosurgery market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, source, application and end user.

Breakup by Product:

Bone-Graft Substitutes

Soft-Tissue Attachments

Hemostatic Agents

Surgical Sealants and Adhesives

Adhesion Barriers

Staple Line Reinforcement

Breakup by Source:

Natural/Biologics Products

Synthetic Products

Breakup by Application:

Orthopedic Surgery

General Surgery

Neurological Surgery

Cardiovascular Surgery

Gynecological Surgery

Others

Breakup by End User:

Hospitals

Clinics

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, CryoLife Inc., CSL Limited, Hemostasis LLC, Integra Lifesciences Holdings Corporation, Johnson & Johnson, Medtronic plc, Pfizer Inc., Sanofi S.A., Smith & Nephew plc, Stryker Corporation and Surgalign Spine Technologies Inc.

Key Questions Answered in This Report:

  • How has the global biosurgery market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global biosurgery market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the source?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global biosurgery market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biosurgery Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Bone-Graft Substitutes
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Soft-Tissue Attachments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Hemostatic Agents
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Surgical Sealants and Adhesives
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Adhesion Barriers
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Staple Line Reinforcement
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Source

  • 7.1 Natural/Biologics Products
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Synthetic Products
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Orthopedic Surgery
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 General Surgery
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Neurological Surgery
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Cardiovascular Surgery
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Gynecological Surgery
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 B. Braun Melsungen AG
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 SWOT Analysis
    • 15.3.2 Baxter International Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Becton Dickinson and Company
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 CryoLife Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 CSL Limited
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Hemostasis LLC
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Integra Lifesciences Holdings Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Johnson & Johnson
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Medtronic plc
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Pfizer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Sanofi S.A.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Smith & Nephew plc
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Stryker Corporation
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis
    • 15.3.14 Surgalign Spine Technologies Inc.
      • 15.3.14.1 Company Overview
      • 15.3.14.2 Product Portfolio
      • 15.3.14.3 Financials